Tenet Healthcare (NYSE:THC) Director Sells $532,050.00 in Stock

Tenet Healthcare Corporation (NYSE:THC) Director Nadja West sold 3,000 shares of the company’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the completion of the sale, the director owned 24,805 shares in the company, valued at approximately $4,399,166.75. This trade represents a 10.79% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Tenet Healthcare Price Performance

THC opened at $174.83 on Friday. The firm has a market cap of $15.06 billion, a price-to-earnings ratio of 9.09, a price-to-earnings-growth ratio of 1.15 and a beta of 1.30. Tenet Healthcare Corporation has a fifty-two week low of $146.60 and a fifty-two week high of $247.21. The company’s 50-day moving average price is $189.94 and its 200 day moving average price is $201.87. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, topping the consensus estimate of $4.21 by $0.61. The firm had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. Tenet Healthcare’s quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, sell-side analysts expect that Tenet Healthcare Corporation will post 17.67 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts recently weighed in on THC shares. Stephens dropped their price objective on shares of Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. Leerink Partners raised their price target on shares of Tenet Healthcare from $255.00 to $264.00 and gave the company an “outperform” rating in a research note on Friday, February 20th. Jefferies Financial Group raised their price target on shares of Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a research note on Thursday, February 12th. KeyCorp dropped their price target on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Finally, UBS Group raised their price target on shares of Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a research note on Thursday, February 12th. Nineteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Tenet Healthcare currently has an average rating of “Moderate Buy” and an average price target of $244.16.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Price T Rowe Associates Inc. MD boosted its holdings in Tenet Healthcare by 1.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,490,350 shares of the company’s stock worth $1,488,484,000 after buying an additional 119,809 shares in the last quarter. Boston Partners boosted its holdings in Tenet Healthcare by 15.7% during the fourth quarter. Boston Partners now owns 3,642,136 shares of the company’s stock worth $723,804,000 after buying an additional 494,581 shares in the last quarter. AQR Capital Management LLC boosted its holdings in Tenet Healthcare by 20.3% during the fourth quarter. AQR Capital Management LLC now owns 2,256,539 shares of the company’s stock worth $448,419,000 after buying an additional 380,116 shares in the last quarter. Ameriprise Financial Inc. boosted its holdings in Tenet Healthcare by 8.0% during the second quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock worth $373,020,000 after buying an additional 157,109 shares in the last quarter. Finally, Norges Bank bought a new stake in Tenet Healthcare during the fourth quarter worth approximately $248,494,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.